Response to the roadmap to the European Commission’s Pharmaceutical StrategyComments Off on Response to the roadmap to the European Commission’s Pharmaceutical Strategy

European doctors contributed to the forthcoming European Commission’s Pharmaceutical Strategy by providing their comments on the recently published roadmap.

We emphasise the importance of regaining the trust in the pharma sector and rebuilding the confidence in the patient-centred system that serves public interests.

CPME agrees with the roadmap that the strategy must be patient-centred. It must serve public interests and properly define the role of pharmaceutical industry as a contributor to public health.

We believe that the roadmap provides a fair overview of the current problems the pharmaceutical system in the EU is confronted with and provide a set of recommendations on how to tackle them.

See our response to the roadmap: https://www.cpme.eu/index.php?downloadunprotected=/uploads/adopted/2020/7/CPME_AD_EC_06072020.FINAL_.CPME_.Response.to_.the_.roadmap.to_.the_.pharmaceutical.strategy.pdf